eli lilly - Search News

News

Eli Lilly sues Mochi Health and others

CNBC on MSN · 23h

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro. Lilly claims Mochi Health,

UPI on MSN · 19h

Eli Lilly sues telehealth companies for selling Mounjaro, Zepbound compounds

Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs.

Markets Insider · 21h

Eli Lilly Stock (LLY) Back in Shape as It Sues Compounders Over Weight-Loss Drugs

Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss and diabetes

2don MSN

Novo Nordisk Shares Fall After Data From New Eli Lilly Pill

Shares fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s ...

3don MSN

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

6d

Why It Makes Sense To Buy Eli Lilly Stock At $840

The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve ...

16h

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Eli Lilly has filed a lawsuit against four telehealth platforms selling compounded versions of its blockbuster metabolic ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results